Perking Up

Fly Charts: Dr. Pepper Coffee Alliance, Biotech Bonanza

From looking to the top line to the pound's resilience, here are four charts that tell you what you need to know in business today.

Good morning! This is Fly Charts, the daily charts-only newsletter from Gadfly; sign up here. From looking to the top line to the pound's resilience, here are four charts that tell you what you need to know in business today.

Surprise!

Tax cuts are making a mess of profit numbers right now; revenue may be a better gauge of corporate strength, and it looked good in the fourth quarter.

Source: FactSet Research Systems

Data through Jan. 25, 2017. 4Q numbers based on companies that had been reported to date.

Sugary Sweet

JAB's aggressive coffee deal-making has turned it into "the Budweiser of coffee." Its Dr. Pepper foray serves as notice for Coke that it has broader ambitions.

Source: Bloomberg

Bargain Shopping

Sanofi's big Ablynx premium is a sign that getting biotech deals done this year is likely to be very expensive.

Source: Bloomberg

Climbing the Brexit Wall

Sterling is proving shockingly resilient in the face of Brexit uncertainty.

Source: Bloomberg

And don't miss Chris Hughes on a needed reckoning in the U.K.: "The Presidents Club dinner, with its skimpily dressed hostesses and alleged groping, was unusually blatant, and the list of invitees seems to have been weighted to one sector, property. But the furore provides investors across the board with an opportunity to demand better disclosure on corporate culture in general and harassment in particular."

This column does not necessarily reflect the opinion of Bloomberg LP and its owners.

    To contact the author of this story:
    Max Nisen in New York at mnisen@bloomberg.net

    To contact the editor responsible for this story:
    Mark Gongloff at mgongloff1@bloomberg.net

    Before it's here, it's on the Bloomberg Terminal.
    LEARN MORE